Trompeter, R., Yu, V. Y. H., Aynsley-Green, A., and Roberton, N. R. C. (1975) . Archives of Disease in Childhood, 50, 123. Massive pulmonary haemorrhage in the newborn infant. Six cases of massive pulmonary haemorrhage in newborn infants are described. 2 term infants suffered severe birth asphyxia and massive pulmonary haemorrhage presented early (mean 5 hours); in 4 preterm infants massive pulmonary haemorrhage presented late (mean 4 days) while receiving assisted ventilation. All the infants were treated with positive pressure ventilation, vigorous correction ofpH, anaemia, and hypovolaemia, and 4 survived the acute condition. We suggest that the early elective use of intermittent positive pressure ventilation may be effective in controlling the pulmonary haemorrhage.
Massive pulmonary haemorrhage has a characteristic clinical presentation in newborn infants in which acute collapse is accompanied by outpouring of blood-stained fluid from the trachea, mouth, and nose. The condition is usually fatal and is said to occur in 1/1000 live births (Fedrick and Butler, 1971 ). It has been described in association with severe birth asphyxia (Rowe and Avery, 1966) , hypothermia (Mann and Elliott, 1957) , rhesus haemolytic disease (Chessells and Wigglesworth, 1971) , congenital heart disease (Esterly and Oppenheimer, 1966) , small-for-dates infants (Fedrick and Butler, 1971) , and defective coagulation (Chessells and Wigglesworth, 1971) . Though the pathogenesis of the condition is controversial, Cole et al. (1973) have recently suggested that haemorrhagic pulmonary oedema is the end result common to all these conditions. The poor prognosis of massive pulmonary haemorrhage has recently been challenged by Cole and Entress (1974) who described the survival of an infant after treatment with intermittent positive pressure ventilation (IPPV).
We describe our experience with 6 infants presenting with massive pulmonary haemorrhage during the last 15 months. The infants were treated with IPPV early in the course of the disease, and 4 survived the acute illness. Vamin and intralipid regimen (Baum, Aynsley-Green, and Rossiter, 1975) .
Clinical details
The clinical details of the 6 infants are given in Table  I In the 4 infants who survived, CPAP via the endotracheal tube was used to wean them off IPPV. In all infants the massive pulmonary haemorrhage was rapidly controlled after IPPV was instituted, and the lung effluent subsided within 15 minutes. Small amounts of blood-stained secretions were usually aspirated from the trachea for several days after the pulmonary haemorrhage. 4 out of the 6 infants survived the episode of massive pulmoniary haemorrhage.
Case 2 died 7 days later, having been motionless and unresponsive to all stimuli and also had evidently suffered severe brain damage, and Case 5 from peritonitis 9 weeks later. The 2 small premature infants (Cases 3 and 4) continued to deteriorate after the onset of massive pulmonary haemorrhage and died 7 hours and 1 hour later, respectively. Case histories Case 1. A 3350 g, term, female infant was bom in another maternity hospital. She was severely asphyxiated at birth and endotracheal intubation and IPPV were required. A bloody effluent welled up the endotracheal tube from 15 minutes of age. Manual IPPV using a Penlon was continued, and she was transferred to our hospital. On arrival (aged 4 hours) bloody effluent was still flowing up the trachea, and chest x-ray showed opaque lung fields. After correcting the acidaemia she was curarized, and ventilated on the Bennett respirator for 5 hours with a peak airway pressure of 25 cm H2O with only partial improvement.
After the application of positive end-expiratory pressure (PEEP) of 4 cm H20 with the Drager ventilator for 1 hour, there was a marked clinical and radiological improvement. She was transfused with 35 ml fresh blood in 5-10 ml aliquots over this period.
It was then possible to reduce the peak airway pressure and the Fio2 and to wean her off IPPV using CPAP. She was extubated at 36 hours of life and continued to make satisfactory progress. Outpatient follow-up of this infant at 1 month showed satisfactory development and clear chest x-ray. Case 6. A 1290 g, 28-week, female infant was bom 24 hours after an ante-partum haemorrhage. She was apnoeic and was resuscitated by endotracheal intubation and IPPV. Severe respiratory distress syndrome developed, and adequate respiration was not established. Positive pressure ventilation was continued with the Bennett ventilator for 1 hour, changing to CPAP between 2 and 80 hours in an inspired oxygen concentration (FIo2) of 0*8 at an initial pressure of 12 cm H20, decreased subsequently to 5 cm. IPPV was then required for 12 hours because of recurrent apnoeic attacks (peak airway pressure 20-25 cm H2O), followed by a further 20 hours of CPAP. At the age of 149 hours, after a period of unassisted respiration, she had a prolonged apnoeic attack which was followed by bloody effluent welling up the trachea. IPPV in Fio2O O9 was instituted immediately, and 5 ml 7% THAM given to correct the metabolic acidosis (pH 7 -05, BE 20 mEq/l). Chest x-ray at this time showed totally opaque lungs.
She was given digitalis and 2 doses of frusemide 5 mg intravenously 1 hour apart, and 0. 15 mg morphine was given intramuscularly. 50 ml of packed cells were transfused over the next 12 hours to maintain the blood pressure and raise the packed cell volume which had fallen to 34%. Mechanical ventilation was continued for 15 hours with a peak airway pressure of 30-40 cm H20. By these means the massive pulmonary haemorrhage was satisfactorily controlled. CPAP was then used for 3 hours to wean her off IPPV, after which oxygen therapy was stopped on the 20th day. Outpatient follow-up at 2 months of age showed normal development and clear chest x-ray.
Discussion
The 6 babies described here provide further support to the hypothesis of Cole et al. (1973) that massive pulmonary haemorrhage is a form of haemorrhagic pulmonary oedema. Where we were able to collect the fluid from the lungs, it always had a haematocrit lower than that of the infant's blood. As in the series reported by Cole, the 6 infants we describe were critically ill and suffering from a similar spectrum of conditions including intrapartum asphyxia, hyaline membrane disease, hypothermia, and blood coagulation defect, which could precipitate left ventricular failure and haemorrhagic pulmonary oedema. In this series massive pulmonary haemorrhage was seen in two distinct situations: in the first few hours of life in 2 infants who had suffered severe intrapartum asphyxia, and much later (39-149 hours) in 4 low birthweight infants with severe pre-existing lung disease.
There is no established treatment for preventing the high mortality of massive pulmonary haemorrhage (Avery and Fletcher, 1974) . Since IPPV is an effective form of therapy in severe pulmonary oedema from other causes, we have used it electively in the early management of massive pulmonary haemorrhage. In addition to IPPV, our treatment included adequate oxygenation, correction of acidosis, together with digoxin, morphia, and frusemide. The haematocrit and blood pressure were corrected by frequent smaU fresh blood transfusions, particularly when there was evidence of consumption coagulopathy.
Using this approach, it was possible to resuscitate 4 infants after their massive pulmonary haemorrhage, and though 2 of the infants subsequently died, this was not the result of pulmonary disease. In Cases 3 and 4 pulmonary haemorrhage was controlled by IPPV, but irreversible respiratory failure had taken place and proved fatal.
We therefore recommend that massive pulmonary haemorrhage should be treated by elective IPPV irrespective of other indications for this form of therapy. This should be combined with vigorous correction of pH, anaemia, and hypovolaemia, by intravenous alkali and blood transfusion.
in the newborn infant. 
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